I stumbled across EOS last week through a friend and perhaps some of you can help me out with some questions.
Cash at hand at a quarterly basis can be a volatile number, but at the end of Q2 2014 cash came in at 1,541.000. Management stated at the end of last month that cash at the end of Q2 2015 will exceed 10 million. So, at least plus 8,5 million at an annual basis. The enterprise value is just 44,5 million dollar (56,75 million shares x share price 0,96 dollar minus 10 million cash). Are we looking at a value trap or is management correct in repeatedly saying in the company update of the 29th of may: "OUR TIME HAS COME"?
The company seems to have invested around 100 million in the years past and products are market ready. Will lower investments indeed drive profits? The new orders in 2015 look encouraging. Besides, I do like the fact that there has been no dilution of shares over the years.
- Forums
- ASX - By Stock
- Valuation
EOS
electro optic systems holdings limited
Add to My Watchlist
3.66%
!
$2.63

I stumbled across EOS last week through a friend and perhaps...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.63 |
Change
-0.100(3.66%) |
Mkt cap ! $507.4M |
Open | High | Low | Value | Volume |
$2.83 | $2.88 | $2.59 | $5.117M | 1.855M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5769 | $2.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.66 | 6260 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5769 | 2.620 |
1 | 1908 | 2.610 |
1 | 5000 | 2.600 |
1 | 155 | 2.580 |
1 | 4500 | 2.570 |
Price($) | Vol. | No. |
---|---|---|
2.660 | 6260 | 2 |
2.720 | 5000 | 1 |
2.730 | 3663 | 1 |
2.740 | 1670 | 2 |
2.750 | 65000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
EOS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online